- Liraglutide (CAS 204656-20-2) is a synthetic glucagon-like peptide-1 (GLP-1) receptor agonist API, renowned for its powerful and sustainable weight-loss effects. Its bioactive molecular structure mimics the natural GLP-1 hormone, effectively suppressing appetite, slowing gastric emptying, and regulating glucose metabolism—delivering dual benefits of weight management and metabolic health.
- As a high-purity pharmaceutical raw material, it exhibits excellent potency and stability, adhering to global pharmacopoeial standards. Beyond core weight-loss benefits, it supports healthy blood sugar control and reduces cravings for high-calorie foods, making it ideal for formulating medications targeting obesity and related metabolic disorders.
- For pharmaceutical manufacturers and healthcare product developers, this API offers a science-backed solution to meet the growing demand for safe, effective weight-management ingredients. Its mechanism of action aligns with physiological processes, ensuring tolerability and long-term compliance for users seeking sustainable weight loss.

Weight-Loss Liraglutide (CAS 204656-20-2)
$3,500.00
Weight-Loss Liraglutide is a bioactive peptide primarily used for its targeted biological effects in pharmaceutical, cosmetic, and research applications, including tissue repair, anti-aging, and therapeutic development.






Reviews
There are no reviews yet.